Levon Resources (LVNVF) 0.4500 $LVNVF
Levon Resources Ltd.: Press Release
Marketwired - Thu Apr 21, 6:49PM CDT
Levon Resources Ltd. (TSX: LVN)(OTCQX: LVNVF) ("Levon"
has acquired ownership and control of 3,000,000 common shares in the capital of Great Thunder Gold Corp. (the "Issuer", at a deemed price of $0.05 per share, as consideration for the sale by Levon to the Issuer of Levon's 50% interest in the BRX Property located in the Lillooet mining division of southwestern British Columbia, on April 20, 2016.
LVN.TO: 0.58 (+0.09)
Levon Resources to Trade as LVNVF on OTCQX(R)
Marketwired - Thu Jan 14, 8:03AM CST
Levon Resources Ltd. ("Levon" or "the Company" (TSX: LVN)(OTCQX: LVNVF) is pleased to announce that, effective January 14, 2016, its common shares will trade on the OTCQX marketplace in the U.S., under the ticker LVNVF. Levon has traded on the OTCQX since September 14, 2015, under the ticker LVVNF. Trading on OTCQX is designed to provide current and future U.S. based shareholders with greater access to and ease of trading in the Company's shares. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for Levon Resources Ltd. on www.otcmarkets.com.
LVN.TO: 0.58 (+0.09)
Stone's Throw Capital Inc. Increases Ownership of Levon Resources Ltd.
Marketwired - Mon Nov 30, 8:02AM CST
Stone's Throw Capital Inc. (the "Acquiror" wishes to announce that on November 27, 2015, the Acquiror acquired, by way purchase in the open market, ownership and control of 72,500 common shares ("Shares" of Levon Resources Ltd. (the "Company" at a price of $0.135 per Share.
Levon Resources Begins Trading on OTCQX(R)
Marketwired - Mon Sep 14, 6:01AM CDT
Levon Resources Ltd. ("Levon" or "the Company" (TSX: LVN)(OTCQX: LVVNF) is pleased to announce that its common shares will commence trading on the OTCQX market in the U.S., effective September 14, 2015 under the ticker LVVNF. Trading on OTCQX is designed to provide current and future U.S. based shareholders with greater access to and ease of trading in the Company's shares. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for Levon Resources Ltd. on www.otcmarkets.com.
LVN.TO: 0.58 (+0.09)
OTC Markets Group Welcomes Levon Resources to OTCQX
PR Newswire - Mon Sep 14, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial markets, today announced Levon Resources Ltd. (TSX: LVN; OTCQX: LVVNF), a gold and precious metals exploration company, has qualified to trade on the OTCQX® Best Market.
LVN.TO: 0.58 (+0.09)
Frost Closes SciVac Deal, A Potential Blockbuster Lineup in Hepatitis
ACCESSWIRE - Wed Aug 05, 11:20AM CDT
NEW YORK, NY / ACCESSWIRE / August 5, 2015 / Towards the end of last year, we got word that Dr Phillip Frost, chairman and CEO of Opko Health, Inc. (OPK), was looking to restructure then private company SciVac (now SciVac Therapeutics Inc. (SVACF)) into a public entity. Little more was heard of the matter until March 2015, when gold and precious metals exploration company Levon Resources Ltd announced that it had entered into an agreement pursuant to which Levon would acquire 100% of the issued and outstanding ordinary shares of SciVac. OPKO had a 45% stake in SciVac, and so the deal would see current SciVac owners take 68.4% of the outstanding shares of the new company after its close, and Opko take a little over 30%. At first glance the arrangement can seem a little bit convoluted, but a closer look reveals it is very similar in structure to a number of other public shell spins Frost has orchestrated in the past.
OPK: 10.08 (+0.02)
Levon Provides Update on TSX Listing
Marketwired - Tue Jul 14, 7:31AM CDT
Levon Resources Ltd. (TSX: LVN) (formerly 1027949 B.C. Ltd.) ("Levon" or the "Company" is pleased to announce that the common shares of Levon (the "Common Shares" have commenced trading on the Toronto Stock Exchange ("TSX" under the stock symbol "LVN" following the completion of the previously announced plan of arrangement (the "Arrangement" involving SciVac Therapeutics Inc. (formerly Levon Resources Ltd.) ("SciVac" or "Old Levon", as the context requires), SciVac Ltd. and the Company dated March 19, 2015. The Company has 119,542,711 Common Shares outstanding as of July 14, 2015. The Company also announced its intention to have the Common Shares quoted on the OTCQX in the United States. A further announcement will be made on such listing being obtained.
LVN.TO: 0.58 (+0.09)
SciVac Announces Listing on the Toronto Stock Exchange
Marketwire Canada - Mon Jul 13, 9:44PM CDT
SciVac Therapeutics Inc. (the "Company", formerly Levon Resources Ltd.) (TSX:VAC)(OTCQX:SVACF) is pleased to announce that the Toronto Stock Exchange (the "TSX" has issued a bulletin confirming the listing of the Company's common shares (the "Common Shares" on the TSX under the symbol "VAC", commencing at the opening of the TSX on July 14, 2015. Also commencing at the opening of markets on July 14, 2015, the Common Shares will be quoted on the OTCQX under the symbol "SVACF".
VAC.TO: 5.76 (+0.56)
CLS Therapeutics Limited Acquires Shares of SciVac Therapeutics Inc.
CNW Group - Fri Jul 10, 6:42PM CDT
CLS Therapeutics Limited ("CLS" acquired ownership of 147,403,443 common shares ("Common Shares" of SciVac Therapeutics Inc. (the "Company" (formerly Levon Resources Ltd. ("Levon") representing 19.5% of the issued and outstanding Common Shares of the Company effective July 9, 2015. Prior to the transaction, CLS did not own any of the issued and outstanding Common Shares of the Company.
OPKO Investee SciVac Announces the Completion of Transaction with Levon Resources
BusinessWire - Fri Jul 10, 8:00AM CDT
OPKO Health, Inc. (NYSE:OPK) is pleased to announce that SciVac Ltd. ("SciVac", an Israeli entity in which OPKO has a forty-five percent ownership interest, completed its previously announced plan of arrangement under Section 288 of the Business Corporations Act (British Columbia) (the "Transaction" with SciVac Therapeutics Inc. (the "Company," formerly Levon Resources Ltd. ("Levon"), pursuant to which the Company acquired 100% of the issued and outstanding securities of SciVac in exchange for common shares of the Company (the "Common Shares". The terms and conditions on which the Transaction was completed were set out in the arrangement agreement dated March 19, 2015 (the "Arrangement Agreement" among Levon, SciVac and 1027949 B.C. Ltd.
OPK: 10.08 (+0.02)
SciVac Announces the Completion of Reverse Takeover Transaction
Marketwired - Thu Jul 09, 8:26AM CDT
SciVac Therapeutics Inc. (the "Company", formerly Levon Resources Ltd.) ("Levon" is pleased to announce the completion of the previously announced plan of arrangement (the "Transaction" pursuant to which SciVac Ltd. ("SciVac" completed a reverse takeover of Levon. In connection with the Transaction, the Company acquired 100% of the issued and outstanding securities of SciVac in exchange for 517,514,016 common shares (the "Common Shares" of the Company, resulting in the former SciVac securityholders holding 68.4% of the issued and outstanding Common Shares and the Levon shareholders immediately prior to the effective time of the Transaction controlling the remaining 31.6%. On completion of the Transaction, the Company changed its name from Levon Resources Ltd. to SciVac Therapeutics Inc.
Levon Announces Completion of Arrangement
Marketwired - Thu Jul 09, 8:26AM CDT
Levon Resources Ltd. (formerly 1027949 B.C. Ltd.) ("Levon" or the "Company" is pleased to announce the completion of the previously announced plan of arrangement (the "Arrangement" pursuant to which, among other things, SciVac Ltd. ("SciVac" completed a reverse takeover of SciVac Therapeutics Inc. (formerly Levon Resources Ltd.) ("New SciVac" or "Old Levon", as the context requires). Pursuant to the Arrangement, among other things, shareholders of Old Levon immediately prior to the Arrangement received one new common share of New SciVac (each, a "New SciVac Share" and 0.5 of a common share of Levon (each, a "Levon Share" in exchange for each common share of Old Levon held by such shareholder immediately prior to the effective time of the Arrangement (the "Effective Time", for a total issuance of 239,085,423 New SciVac Shares and 119,542,711 Levon Shares. As a result of the Arrangement, former shareholders of Old Levon hold 100% of the issued and outstanding Levon Shares immediately after completion of the Arrangement. In connection with the Arrangement, the Company changed its name from "1027949 B.C. Ltd." to "Levon Resources Ltd." immediately after New SciVac changed its name from "Levon Resources Ltd." to "SciVac Therapeutics Inc.". The Company will continue to operate the junior mining business of Old Levon immediately prior to the Arrangement.
Levon Resources Ltd.: Press Release
Marketwired - Thu Apr 21, 6:49PM CDT
Levon Resources Ltd. (TSX: LVN)(OTCQX: LVNVF) ("Levon"
has acquired ownership and control of 3,000,000 common shares in the capital of Great Thunder Gold Corp. (the "Issuer", at a deemed price of $0.05 per share, as consideration for the sale by Levon to the Issuer of Levon's 50% interest in the BRX Property located in the Lillooet mining division of southwestern British Columbia, on April 20, 2016. LVN.TO: 0.58 (+0.09)
Levon Resources to Trade as LVNVF on OTCQX(R)
Marketwired - Thu Jan 14, 8:03AM CST
Levon Resources Ltd. ("Levon" or "the Company"
(TSX: LVN)(OTCQX: LVNVF) is pleased to announce that, effective January 14, 2016, its common shares will trade on the OTCQX marketplace in the U.S., under the ticker LVNVF. Levon has traded on the OTCQX since September 14, 2015, under the ticker LVVNF. Trading on OTCQX is designed to provide current and future U.S. based shareholders with greater access to and ease of trading in the Company's shares. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for Levon Resources Ltd. on www.otcmarkets.com. LVN.TO: 0.58 (+0.09)
Stone's Throw Capital Inc. Increases Ownership of Levon Resources Ltd.
Marketwired - Mon Nov 30, 8:02AM CST
Stone's Throw Capital Inc. (the "Acquiror"
wishes to announce that on November 27, 2015, the Acquiror acquired, by way purchase in the open market, ownership and control of 72,500 common shares ("Shares" of Levon Resources Ltd. (the "Company" at a price of $0.135 per Share. Levon Resources Begins Trading on OTCQX(R)
Marketwired - Mon Sep 14, 6:01AM CDT
Levon Resources Ltd. ("Levon" or "the Company"
(TSX: LVN)(OTCQX: LVVNF) is pleased to announce that its common shares will commence trading on the OTCQX market in the U.S., effective September 14, 2015 under the ticker LVVNF. Trading on OTCQX is designed to provide current and future U.S. based shareholders with greater access to and ease of trading in the Company's shares. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for Levon Resources Ltd. on www.otcmarkets.com. LVN.TO: 0.58 (+0.09)
OTC Markets Group Welcomes Levon Resources to OTCQX
PR Newswire - Mon Sep 14, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial markets, today announced Levon Resources Ltd. (TSX: LVN; OTCQX: LVVNF), a gold and precious metals exploration company, has qualified to trade on the OTCQX® Best Market.
LVN.TO: 0.58 (+0.09)
Frost Closes SciVac Deal, A Potential Blockbuster Lineup in Hepatitis
ACCESSWIRE - Wed Aug 05, 11:20AM CDT
NEW YORK, NY / ACCESSWIRE / August 5, 2015 / Towards the end of last year, we got word that Dr Phillip Frost, chairman and CEO of Opko Health, Inc. (OPK), was looking to restructure then private company SciVac (now SciVac Therapeutics Inc. (SVACF)) into a public entity. Little more was heard of the matter until March 2015, when gold and precious metals exploration company Levon Resources Ltd announced that it had entered into an agreement pursuant to which Levon would acquire 100% of the issued and outstanding ordinary shares of SciVac. OPKO had a 45% stake in SciVac, and so the deal would see current SciVac owners take 68.4% of the outstanding shares of the new company after its close, and Opko take a little over 30%. At first glance the arrangement can seem a little bit convoluted, but a closer look reveals it is very similar in structure to a number of other public shell spins Frost has orchestrated in the past.
OPK: 10.08 (+0.02)
Levon Provides Update on TSX Listing
Marketwired - Tue Jul 14, 7:31AM CDT
Levon Resources Ltd. (TSX: LVN) (formerly 1027949 B.C. Ltd.) ("Levon" or the "Company"
is pleased to announce that the common shares of Levon (the "Common Shares" have commenced trading on the Toronto Stock Exchange ("TSX" under the stock symbol "LVN" following the completion of the previously announced plan of arrangement (the "Arrangement" involving SciVac Therapeutics Inc. (formerly Levon Resources Ltd.) ("SciVac" or "Old Levon", as the context requires), SciVac Ltd. and the Company dated March 19, 2015. The Company has 119,542,711 Common Shares outstanding as of July 14, 2015. The Company also announced its intention to have the Common Shares quoted on the OTCQX in the United States. A further announcement will be made on such listing being obtained. LVN.TO: 0.58 (+0.09)
SciVac Announces Listing on the Toronto Stock Exchange
Marketwire Canada - Mon Jul 13, 9:44PM CDT
SciVac Therapeutics Inc. (the "Company", formerly Levon Resources Ltd.) (TSX:VAC)(OTCQX:SVACF) is pleased to announce that the Toronto Stock Exchange (the "TSX"
has issued a bulletin confirming the listing of the Company's common shares (the "Common Shares" on the TSX under the symbol "VAC", commencing at the opening of the TSX on July 14, 2015. Also commencing at the opening of markets on July 14, 2015, the Common Shares will be quoted on the OTCQX under the symbol "SVACF". VAC.TO: 5.76 (+0.56)
CLS Therapeutics Limited Acquires Shares of SciVac Therapeutics Inc.
CNW Group - Fri Jul 10, 6:42PM CDT
CLS Therapeutics Limited ("CLS"
acquired ownership of 147,403,443 common shares ("Common Shares" of SciVac Therapeutics Inc. (the "Company" (formerly Levon Resources Ltd. ("Levon") representing 19.5% of the issued and outstanding Common Shares of the Company effective July 9, 2015. Prior to the transaction, CLS did not own any of the issued and outstanding Common Shares of the Company. OPKO Investee SciVac Announces the Completion of Transaction with Levon Resources
BusinessWire - Fri Jul 10, 8:00AM CDT
OPKO Health, Inc. (NYSE:OPK) is pleased to announce that SciVac Ltd. ("SciVac"
, an Israeli entity in which OPKO has a forty-five percent ownership interest, completed its previously announced plan of arrangement under Section 288 of the Business Corporations Act (British Columbia) (the "Transaction" with SciVac Therapeutics Inc. (the "Company," formerly Levon Resources Ltd. ("Levon"), pursuant to which the Company acquired 100% of the issued and outstanding securities of SciVac in exchange for common shares of the Company (the "Common Shares". The terms and conditions on which the Transaction was completed were set out in the arrangement agreement dated March 19, 2015 (the "Arrangement Agreement" among Levon, SciVac and 1027949 B.C. Ltd. OPK: 10.08 (+0.02)
SciVac Announces the Completion of Reverse Takeover Transaction
Marketwired - Thu Jul 09, 8:26AM CDT
SciVac Therapeutics Inc. (the "Company", formerly Levon Resources Ltd.) ("Levon"
is pleased to announce the completion of the previously announced plan of arrangement (the "Transaction" pursuant to which SciVac Ltd. ("SciVac" completed a reverse takeover of Levon. In connection with the Transaction, the Company acquired 100% of the issued and outstanding securities of SciVac in exchange for 517,514,016 common shares (the "Common Shares" of the Company, resulting in the former SciVac securityholders holding 68.4% of the issued and outstanding Common Shares and the Levon shareholders immediately prior to the effective time of the Transaction controlling the remaining 31.6%. On completion of the Transaction, the Company changed its name from Levon Resources Ltd. to SciVac Therapeutics Inc. Levon Announces Completion of Arrangement
Marketwired - Thu Jul 09, 8:26AM CDT
Levon Resources Ltd. (formerly 1027949 B.C. Ltd.) ("Levon" or the "Company"
is pleased to announce the completion of the previously announced plan of arrangement (the "Arrangement" pursuant to which, among other things, SciVac Ltd. ("SciVac" completed a reverse takeover of SciVac Therapeutics Inc. (formerly Levon Resources Ltd.) ("New SciVac" or "Old Levon", as the context requires). Pursuant to the Arrangement, among other things, shareholders of Old Levon immediately prior to the Arrangement received one new common share of New SciVac (each, a "New SciVac Share" and 0.5 of a common share of Levon (each, a "Levon Share" in exchange for each common share of Old Levon held by such shareholder immediately prior to the effective time of the Arrangement (the "Effective Time", for a total issuance of 239,085,423 New SciVac Shares and 119,542,711 Levon Shares. As a result of the Arrangement, former shareholders of Old Levon hold 100% of the issued and outstanding Levon Shares immediately after completion of the Arrangement. In connection with the Arrangement, the Company changed its name from "1027949 B.C. Ltd." to "Levon Resources Ltd." immediately after New SciVac changed its name from "Levon Resources Ltd." to "SciVac Therapeutics Inc.". The Company will continue to operate the junior mining business of Old Levon immediately prior to the Arrangement. 
